Cholesterol-regulated cellular stiffness may enhance evasion of NK cell-mediated cytotoxicity in gastric cancer stem cells

FEBS Open Bio. 2024 May;14(5):855-866. doi: 10.1002/2211-5463.13793. Epub 2024 Mar 17.

Abstract

Gastric cancer has a high rate of recurrence, and as such, immunotherapy strategies are being investigated as a potential therapeutic strategy. Although the involvement of immune checkpoints in immunotherapy is well studied, biomechanical cues, such as target cell stiffness, have not yet been subject to the same level of investigation. Changes in the cholesterol content of the cell membrane directly influence tumor cell stiffness. Here, we investigated the effect of cholesterol on NK cell-mediated killing of gastric cancer stem-like cells. We report that surviving tumor cells with stem-like properties elevated cholesterol metabolism to evade NK cell cytotoxicity. Inhibition of cholesterol metabolism enhances NK cell-mediated killing of gastric cancer stem-like cells, highlighting a potential avenue for improving immunotherapy efficacy. This study suggests a possible effect of cancer cell stiffness on immune evasion and offers insights into enhancing immunotherapeutic strategies against tumors.

Keywords: NK cell; SREBP2; cancer stem cells; cholesterol; gastric cancer; immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cholesterol* / metabolism
  • Cytotoxicity, Immunologic
  • Humans
  • Immunotherapy / methods
  • Killer Cells, Natural* / immunology
  • Killer Cells, Natural* / metabolism
  • Neoplastic Stem Cells* / immunology
  • Neoplastic Stem Cells* / metabolism
  • Stomach Neoplasms* / immunology
  • Stomach Neoplasms* / pathology
  • Tumor Escape / immunology

Substances

  • Cholesterol